New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 14, 2014
18:15 EDTPPHM, SAVE, APOL, NURO, VLO, TSO, HFC, MPCOn The Fly: After Hours Movers
UP AFTER EARNINGS: Peregrine Pharmaceuticals (PPHM), up 2.3% after reports fourth quarter results. ALSO HIGHER: Spirit Airlines (SAVE), up 1.5% after Lone Pine Capital reported a 6% passive stake. LOWER: Apollo Education (APOL), down 6.2% following an announcement that the Department of Education intends to conduct an ordinary course program review of University of Phoenix... Neurometrix (NURO), down just under 1% after the company files to sell 5.89M shares of common stock for holders. NOTABLE: Valero Energy (VLO), down 3.4% after announcing second quarter guidance below analyst estimates... Tesoro (TSO), down almost 1%, HollyFrontier (HFC), down marginally, and Marathon Petroleum (MPC), down fractionally, are also lower following Valero Energy's announcement.
News For PPHM;SAVE;APOL;NURO;VLO;TSO;HFC;MPC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
October 21, 2014
07:34 EDTAPOLApollo Education sees 1Q15 revenue $720M-$730M, consensus $763.70M
Subscribe for More Information
07:33 EDTAPOLApollo Education sees FY15 revenue $2.8B-$2.85B, consensus $2.80B
07:32 EDTAPOLApollo reports Q4 University of Phoenix New Degreed Enrollment down 5.9%
Subscribe for More Information
07:31 EDTAPOLApollo Education reports Q4 EPS from cont. ops. ex-items 34c, consensus 27c
Subscribe for More Information
October 17, 2014
14:50 EDTPPHMBARDA asks labs to ramp up Zmapp production, Reuters says
Subscribe for More Information
09:46 EDTPPHMSarepta soars after publication of Ebola drug candidate data
Subscribe for More Information
October 15, 2014
17:36 EDTSAVESpirit Airlines sees Q3 capacity up 14.7%
Subscribe for More Information
16:47 EDTNURONeuroMetrix files to sell 3.3M shares of common stock for holders
Subscribe for More Information
12:36 EDTPPHMOn The Fly: Midday Wrap
Subscribe for More Information
10:49 EDTPPHMEbola linked names rise again amid broader market sell-off
Subscribe for More Information
10:49 EDTPPHMHigh option volume stocks
High option volume stocks: SNV FCG TXT MDSO PPHM NTRS CCL RGP LLTC SOCL
09:20 EDTPPHMOn The Fly: Pre-market Movers
Subscribe for More Information
08:38 EDTPPHMPeregrine up 21% after saying will examine drug as potential Ebola treatment
08:15 EDTPPHMPeregrine says data support Phosphatidylserine as potential target in Ebola
Peregrine Pharmaceuticals announced the publication of a peer-reviewed manuscript, to appear in the Vaccines and Therapies for Biodefense Agents special edition of the peer-reviewed Journal of Immunology Research in a manuscript titled: "Effective Binding of a Phosphatidylserine-Targeting Antibody to Ebola Virus Infected Cells and Purified Virions," related to preclinical research demonstrating that the company's lead drug candidate bavituximab, a phosphatidylserine-targeting antibody, exhibits specific and strong binding to Ebola virions and Ebola virus-infected cells in vitro. Cyril Empig, Ph.D., associate research director at Peregrine Pharmaceuticals, said, "Our goal with this work was to continue exploring the potential of bavituximab in the antiviral arena and in this case, specifically in biodefense applications. With the increased focus on Ebola, there is an opportunity to take advantage of the specificity of bavituximab for Ebola virus and develop therapeutics or treatment regimens that could neutralize the virus. In addition, recently reported genomic sequence variations in EBOV suggest that drugs targeting specific viral non-variant proteins or protein sequences are at risk of failure as a result of virus escape mutations...Given these data, we are developing a plan to explore potential applications of bavituximab and PS-targeting antibodies in the treatment of Ebola."
07:07 EDTAPOLFor profit education positive catalysts outweigh negative, says Wells Fargo
Wells Fargo expects for-profit education stocks to benefit from improved hiring trends and a sale by Corinthian of its assets that, according t othe firm ,would set a valuation floor for the sector. The firm continues to believe that the final gainful employment rule will be neutral to positive for the group. Wells favors the option value on the long side for the sector. Publicly traded companies in the space include American Public Education (APEI), Apollo Education (APOL), Bridgepoint Education (BPI), Career Education (CECO), Corinthian Colleges (COCO), DeVry (DV), Grand Canyon (LOPE), ITT Educational (ESI) and Strayer (STRA).
05:58 EDTVLOStocks with implied volatility movement; KMI VLO
Subscribe for More Information
October 13, 2014
15:18 EDTSAVESpirit Airlines volatility spikes as shares sell off
Spirit Airlines October call option implied volatility is at 66, September, November is at 68, December is at 59; compared to its 26-week average of 35 according to Track Data, suggesting large price movement.
11:23 EDTTSOStocks with call strike movement; APC TSO
Subscribe for More Information
10:08 EDTMPCOn The Fly: Analyst Initiation Summary
Subscribe for More Information
05:57 EDTMPCMarathon Petroleum reinstated with an Overweight at Barclays
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use